Accretion Nutraveda
Accretion Nutraveda Share Price Chart
Accretion Nutraveda last traded at ₹295.00 (2026-10-13). Over the past month the stock moved +4.6%, three months the stock moved +11.8%. Its closing range over 52 weeks is ₹155.90 – ₹313.00, with the latest close 5.8% below the high.
Closing prices up to 2026-10-13.
About Accretion Nutraveda
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms.[1]
Business Profile[1] Accretion Nutraveda Limited is a healthcare-focused Ayurveda and Nutraceutical CDMO, manufacturing a wide range of Ayurvedic and nutraceutical products across multiple dosage forms for domestic clients, merchant exporters, and direct export customers.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 19.54 | 3.56 | 18.22 | 2.69 | 3.72 |
| Sep 2025 | 14.06 | 3.30 | 23.47 | 2.33 | 4.38 |
| Mar 2025 | 10.85 | 2.58 | 23.78 | 1.72 | 35.32 |
Annual Financials
In the latest year (Mar 2026), Accretion Nutraveda reported sales of ₹33.60 crore (+110.0%) and net profit of ₹5.07 crore (+94.3%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 33.60 | 6.89 | 20.51 | 5.07 | 7.00 |
| Mar 2025 | 16.00 | 3.72 | 23.25 | 2.61 | 53.59 |
| Mar 2024 | 5.01 | 1.23 | 24.55 | 0.82 | 22.78 |
| Mar 2023 | 2.89 | 0.62 | 21.45 | 0.28 | 7.78 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | +73.4% | +219.4% | +110.0% |
| Operating profit growth | +98.4% | +202.4% | +85.2% |
| Net profit growth | +192.9% | +218.3% | +94.3% |
| EPS growth | +192.8% | +135.3% | -86.9% |
| OPM % | 24.6% | 23.3% | 20.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Accretion Nutraveda.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Accretion Nutraveda.
Frequently Asked Questions
What is Accretion Nutraveda's current stock price?
Accretion Nutraveda shares were last quoted at ₹295.00 (+1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Accretion Nutraveda?
Accretion Nutraveda has a price-to-earnings (P/E) ratio of 38.54 and a price-to-book (P/B) ratio of 5.51. The industry P/E is 52.82.
What is the 52-week high and low of Accretion Nutraveda?
The 52-week high of Accretion Nutraveda is ₹313.00 and the 52-week low is ₹150.10.
What is the market cap of Accretion Nutraveda?
The market capitalisation of Accretion Nutraveda is about ₹195.34 crore.
Is Accretion Nutraveda a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Accretion Nutraveda has a 3-year ROE of 35.00%, 3-year profit growth of 163.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Accretion Nutraveda?
Promoters hold about 73.48% of Accretion Nutraveda.
Which sector does Accretion Nutraveda belong to?
Accretion Nutraveda belongs to the Pharmaceuticals & Drugs sector.